The Role of p27 Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of p27 Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells

Published:2011-08-02 Issue:18 Volume:103 Page:1403-1422
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Le Xiao-Feng,Mao Weiqun,He Guangan,Claret Francois-Xavier,Xia Weiya,Ahmed Ahmed Ashour,Hung Mien-Chie,Siddik Zahid H.,Bast Robert C.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/103/18/1403/17311175/djr280.pdf

Reference63 articles.

1. The biology of ovarian cancer: new opportunities for translation;Bast;Nat Rev Cancer.,2009

2. Paclitaxel in cancer therapy;Mekhail;Expert Opin Pharmacother.,2002

3. Taxol (paclitaxel): mechanisms of action;Horwitz;Ann Oncol.,1994

4. Promotion of microtubule assembly in vitro by taxol;Schiff;Nature.,1979

5. Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens) phase II study;Guastalla;Ann Oncol.,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma;Sarcoma;2022-05-12

2. Adenomatous Polyposis Coli Loss Controls Cell Cycle Regulators and Response to Paclitaxel;2020-11-01

3. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers;Clinical Cancer Research;2019-08-07

4. Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib;Molecular Cancer Therapeutics;2016-06-30

5. Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells;Molecular Medicine Reports;2016-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3